Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PILDI study: Perioperative intravenous lidocaine in colon cancer surgery
2025-521808-22-01Phase 2Authorised
- Sponsor
- Institute of Oncology Ljubljana
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in colon cancer comparing Perioperative intravenous lidocaine with Placebo (intravenous sodium chloride) (2 arms). Primary endpoint: Total opioid analgesic consumption at 24 hours. Planned start Feb 2026; status: authorised.
02
Drugs
lidocaine
03
Conditions
colon cancer
Beyond the preview
Go deeper on 2025-521808-22-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521808-22-01.